Deprescribing/Appropriate Prescribing Module
This module discusses safe medication use in older adults in order to maximize therapeutic benefit and reduce poly pharmacy and adverse drug events.
Learning Objectives
- Describe the purpose of Beers Criteria
- Describe the problems resulting from polypharmacy (e.g. prescribing cascade)
- Identify medications that can be considered for deprescribing
- Identify medications that can may be underutilized in the elderly
- Describe adverse drug effects affecting elderly patients associated from inappropriately prescribed medications
Handouts
Andrea Levin, PharmD, BCACP is currently an Assistant Professor of Pharmacy Practice at Nova Southeastern University College of Pharmacy with a practice specialty and board certification in Ambulatory Care. She received her Bachelor's of Science (BS) and Doctor of Pharmacy (Pharm.D.) degrees from Nova Southeastern University. Upon completion of her Pharm.D., she completed a PGY1 pharmacy practice residency with an emphasis in ambulatory care and academia from Florida Hospital-Celebration Health. Dr. Levin then became an Assistant Professor at Long Island University’s Arnold and Marie Schwartz College of Pharmacy and Health Sciences as well as the Clinical Pharmacy Manager for Ambulatory Care at Montefiore Medical Center where she managed patients' anticoagulation, hypertension, dyslipidemia, contraception, and diabetes needs. Currently, Dr. Levin assists in the care of adults with Type 2 Diabetes, Hypertension, and/or Dyslipidemia within the Memorial Healthcare System where she takes students on rotation and teaches in the pharmacotherapy and immunization certification courses at the College of Pharmacy. Dr. Levin has presented for continuing education programs on diabetes, contraception, and deprescribing/appropriate prescribing as well as presented to pharmacists, nurses, and physicians on diabetes and anticoagulation management.
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $3.5M with 25% financed with nongovernmental sources. The contents of this website are those of the author and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.